CLINICAL_TRIALS
research
· 2026-04-24
Clinical Trial Update: A Study of TYRA-300 in Children With Achondroplasia: BEACH301 [Phase 2]
Summary
A Phase 2 study of TYRA-300 in children with achondroplasia (BEACH301) is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tyra Biosciences, Inc | Conditions: Achondroplasia | Phase 2 | Status: RECRUITING